Dry Eye Syndrome Market Size, Share & Industry Analysis, By Product (Anti-inflammatory Products {Cyclosporin, Corticosteroids, and Others}, Artificial Tears and Lubricants, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI102413

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Dry Eye Disease, By Key Countries, 2025
2. Key Industry Developments
3. Pipeline Analysis
4. New Product Launches, By Key Players
5. Reimbursement Policies, By Key Countries/ Regions
6. Regulatory Scenario, By Key Countries/ Regions
7. Overview of Novel Approaches to Treat Dry Eyes
8. Key Industry Trends
9. Healthcare Industry Overview, By Key Countries/ Regions
10. Impact of COVID-19 on Global Dry Eye Syndrome Market
11. Overview of Over the Counter Eye Lubricants In the Market
Global Dry Eye Syndrome Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Anti-inflammatory Products
    1. Cyclosporine
    2. Corticosteroids
    3. Others
  2. Artificial Tears and Lubricants
  3. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Dry Eye Syndrome Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Anti-inflammatory Products
    1. Cyclosporine
    2. Corticosteroids
    3. Others
  2. Artificial Tears and Lubricants
  3. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Dry Eye Syndrome Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Anti-inflammatory Products
    1. Cyclosporine
    2. Corticosteroids
    3. Others
  2. Artificial Tears and Lubricants
  3. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Dry Eye Syndrome Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Anti-inflammatory Products
    1. Cyclosporine
    2. Corticosteroids
    3. Others
  2. Artificial Tears and Lubricants
  3. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Dry Eye Syndrome Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Anti-inflammatory Products
    1. Cyclosporine
    2. Corticosteroids
    3. Others
  2. Artificial Tears and Lubricants
  3. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Dry Eye Syndrome Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Anti-inflammatory Products
    1. Cyclosporine
    2. Corticosteroids
    3. Others
  2. Artificial Tears and Lubricants
  3. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. AbbVie Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Alcon
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Novartis AG
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Santen Pharmaceutical Co., Ltd.
    1. OASIS Medical
    2. Overview
    3. Products & Services
    4. SWOT Analysis
    5. Recent Developments
    6. Strategies
    7. Financials (Based on Availability)
  5. Sun Pharmaceutical Industries Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Otsuka Pharmaceutical Co., Ltd. (Otsuka Holdings, Co., Ltd)
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Sentiss Pharma Pvt. Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Johnson & Johnson Vision Care, Inc. (Johnson & Johnson Services, Inc.)
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. VISUfarma
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Dry Eye Disease, By Key Countries, 2025
2. Key Industry Developments
3. Pipeline Analysis
4. New Product Launches, By Key Players
5. Reimbursement Policies, By Key Countries/ Regions
6. Regulatory Scenario, By Key Countries/ Regions
7. Overview of Novel Approaches to Treat Dry Eyes
8. Key Industry Trends
9. Healthcare Industry Overview, By Key Countries/ Regions
10. Impact of COVID-19 on Global Dry Eye Syndrome Market
11. Overview of Over the Counter Eye Lubricants In the Market
Global Dry Eye Syndrome Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Anti-inflammatory Products
    1. Cyclosporine
    2. Corticosteroids
    3. Others
  2. Artificial Tears and Lubricants
  3. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Dry Eye Syndrome Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Anti-inflammatory Products
    1. Cyclosporine
    2. Corticosteroids
    3. Others
  2. Artificial Tears and Lubricants
  3. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Dry Eye Syndrome Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Anti-inflammatory Products
    1. Cyclosporine
    2. Corticosteroids
    3. Others
  2. Artificial Tears and Lubricants
  3. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Dry Eye Syndrome Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Anti-inflammatory Products
    1. Cyclosporine
    2. Corticosteroids
    3. Others
  2. Artificial Tears and Lubricants
  3. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Dry Eye Syndrome Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Anti-inflammatory Products
    1. Cyclosporine
    2. Corticosteroids
    3. Others
  2. Artificial Tears and Lubricants
  3. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Dry Eye Syndrome Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Product
  1. Anti-inflammatory Products
    1. Cyclosporine
    2. Corticosteroids
    3. Others
  2. Artificial Tears and Lubricants
  3. Others
2. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. AbbVie Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Alcon
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Novartis AG
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Santen Pharmaceutical Co., Ltd.
    1. OASIS Medical
    2. Overview
    3. Products & Services
    4. SWOT Analysis
    5. Recent Developments
    6. Strategies
    7. Financials (Based on Availability)
  5. Sun Pharmaceutical Industries Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Otsuka Pharmaceutical Co., Ltd. (Otsuka Holdings, Co., Ltd)
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Sentiss Pharma Pvt. Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Johnson & Johnson Vision Care, Inc. (Johnson & Johnson Services, Inc.)
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. VISUfarma
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Dry Eye Syndrome Market Value Share (%), By Product, 2025 & 2034

Figure 2: Global Dry Eye Syndrome Market Value Share (%), By Distribution Channel, 2025 & 2034

Figure 3: Global Dry Eye Syndrome Market Value (USD billion), By Region, 2025 & 2034

Figure 4: North America Dry Eye Syndrome Market Value (USD billion), by Product, 2025 & 2034

Figure 5: North America Dry Eye Syndrome Market Value Share (%), by Product, 2025

Figure 6: North America Dry Eye Syndrome Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 7: North America Dry Eye Syndrome Market Value Share (%), by Distribution Channel, 2025

Figure 8: North America Dry Eye Syndrome Market Value (USD billion), by Country, 2025 & 2034

Figure 9: North America Dry Eye Syndrome Market Value Share (%), by Country, 2025

Figure 10: Europe Dry Eye Syndrome Market Value (USD billion), by Product, 2025 & 2034

Figure 11: Europe Dry Eye Syndrome Market Value Share (%), by Product, 2025

Figure 12: Europe Dry Eye Syndrome Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 13: Europe Dry Eye Syndrome Market Value Share (%), by Distribution Channel, 2025

Figure 14: Europe Dry Eye Syndrome Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034

Figure 15: Europe Dry Eye Syndrome Market Value Share (%), by Country/ Sub-Region, 2025

Figure 16: Asia Pacific Dry Eye Syndrome Market Value (USD billion), by Product, 2025 & 2034

Figure 17: Asia Pacific Dry Eye Syndrome Market Value Share (%), by Product, 2025

Figure 18: Asia Pacific Dry Eye Syndrome Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 19: Asia Pacific Dry Eye Syndrome Market Value Share (%), by Distribution Channel, 2025

Figure 20: Asia Pacific Dry Eye Syndrome Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034

Figure 21: Asia Pacific Dry Eye Syndrome Market Value Share (%), by Country/ Sub-Region, 2025

Figure 22: Latin America Dry Eye Syndrome Market Value (USD billion), by Product, 2025 & 2034

Figure 23: Latin America Dry Eye Syndrome Market Value Share (%), by Product, 2025

Figure 24: Latin America Dry Eye Syndrome Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 25: Latin America Dry Eye Syndrome Market Value Share (%), by Distribution Channel, 2025

Figure 26: Latin America Dry Eye Syndrome Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034

Figure 27: Latin America Dry Eye Syndrome Market Value Share (%), by Country/ Sub-Region, 2025

Figure 28: Middle East & Africa Dry Eye Syndrome Market Value (USD billion), by Product, 2025 & 2034

Figure 29: Middle East & Africa Dry Eye Syndrome Market Value Share (%), by Product, 2025

Figure 30: Middle East & Africa Dry Eye Syndrome Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 31: Middle East & Africa Dry Eye Syndrome Market Value Share (%), by Distribution Channel, 2025

Figure 32: Middle East & Africa Dry Eye Syndrome Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034

Figure 33: Middle East & Africa Dry Eye Syndrome Market Value Share (%), by Country/ Sub-Region, 2025

Figure 34: Global Dry Eye Syndrome Market Share (%), By Company, 2025

List of Tables

Table 1: Global Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Product, 2021-2034

Table 2: Global Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Anti-inflammatory Products, 2021-2034

Table 3: Global Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 4: Global Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Region, 2021-2034

Table 5: North America Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Product, 2021-2034

Table 6: North America Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Anti-inflammatory Products, 2021-2034

Table 7: North America Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 8: North America Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 9: Europe Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Product, 2021-2034

Table 10: Europe Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Anti-inflammatory Products, 2021-2034

Table 11: Europe Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 12: Europe Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 13: Asia Pacific Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Product, 2021-2034

Table 14: Asia Pacific Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Anti-inflammatory Products, 2021-2034

Table 15: Asia Pacific Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 16: Asia Pacific Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 17: Latin America Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Product, 2021-2034

Table 18: Latin America Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Anti-inflammatory Products, 2021-2034

Table 19: Latin America Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 20: Latin America Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 21: Middle East & Africa Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Product, 2021-2034

Table 22: Middle East & Africa Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Anti-inflammatory Products, 2021-2034

Table 23: Middle East & Africa Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 24: Middle East & Africa Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 163

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com